Arca
Skip to content
Tools
Tools

Complex regional pain syndrome

Drug research and approvals for complex regional pain syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 33 studies of complex regional pain syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and FDA has 0 approved and 14 open orphan designations naming it.

  • Recruiting worldwide: 33
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 33 recruiting on ClinicalTrials.gov ↗

How its trials ended

171 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 38 whose ending is known, 18% met their primary endpoint, 5% missed it and 76% stopped early.

  • Completed, result not reported6437%
  • Ongoing4627%
  • Status unknown2313%
  • Stopped: other or unclear138%
  • Stopped: enrollment or feasibility106%
  • Met its primary endpoint74%
  • Stopped: sponsor or business decision42%
  • Missed its primary endpoint21%
  • Stopped: lack of efficacy11%
  • Stopped: funding11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Apr 29, 2021Peripheral nerve injections for the treatment of upper extremity complex regional pain syndrome: a feasibility study for randomized placebo-controlled trialTriamcinoloneOttawa Hospital Research InstituteOngoing
Oct 16, 2019An open-label trial assessing the optimal dose efficacy and safety of GBM-5 in the treatment of pain associated with complex regional pain syndromeGBM-5 (morphine-bupivacaine-ketamine-naloxone-clonidine) / GBC-01…Gilbert Blaise IncPending
Jul 13, 2018Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)Neridronic acidGrunenthal GmbHOngoing

FDA orphan designations

Approved first, then open designations, newest first
Jan 23, 2026PsilocybinTreatment of complex regional pain syndromeCy Biopharma AGDesignated
Nov 20, 2024AfatinibTreatment of complex regional pain syndromeAkigai AsDesignated
Nov 20, 2024High cannabidiol botanical extractTreatment of complex regional pain syndromeBiopharmaceutical Research Company, LLCDesignated
Jun 6, 2022KetamineTreatment of Complex Regional Pain SyndromeVitalis Analgesics, LLCDesignated
Oct 12, 2021KetamineTreatment of Complex Regional Pain Syndrome (CRPS)PharmaTher Inc.Designated
Jun 14, 2021NaltrexoneTreatment of Complex Regional Pain SyndromeSoin TheraputicsDesignated
May 10, 2021KetamineTreatment of Complex Regional Pain SyndromeiX Biopharma Ltd.Designated
Feb 1, 2019KetamineTreatment of Complex Regional Pain SyndromeBexson Biomedical, Inc.Designated
Mar 7, 2018Delta-9-tetrahydrocannabinol and cannabidiolTreatment of complex regional pain syndromePhytoPain Pharma Inc.Designated
Jun 16, 2016Hydromorphone hydrochloride (intrathecal infusion)Treatment of complex regional pain syndromePiramal Critical Care, Inc.Designated
Oct 28, 2015BaclofenTreatment of complex regional pain syndromePiramal Critical Care, Inc.Designated
Apr 15, 2015Zoledronate D,L-lysine monohydrate (ZLM)Treatment of complex regional pain syndrome (CRPS)Thar Pharma, LLCDesignated
May 6, 2013Zoledronic acidTreatment of complex regional pain syndromeAxsome Therapeutics, Inc.Designated
Mar 25, 2013NeridronateTreatment of complex regional pain syndrome (CRPS-1, CRPS-II, CRPS-NOS)Ambros Therapeutics, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.